cRGD-targeted heparin nanoparticles for effective dual drug treatment of cisplatin-resistant ovarian cancer
Xiaomei Liang, Yulu Yang, Chuanqing Huang, Zhibin Ye, Wujiang Lai, Jiamao Luo, Xiaoxuan Li, Yi Xiao, Jun‐Bing Fan, Ying Wang, Yifeng Wang
Topics & Concepts
Ovarian cancerHeparanaseOlaparibNanocarriersCisplatinCancer researchTopotecanDrug resistancePharmacologyMetastasisPI3K/AKT/mTOR pathwayPaclitaxelMedicineCancerChemistryChemotherapyBiologyDrugInternal medicineSignal transductionPoly ADP ribose polymeraseBiochemistryPolymeraseMicrobiologyGenePARP inhibition in cancer therapyLung Cancer Research StudiesPeptidase Inhibition and Analysis